PL365567A1 - Sposoby wytwarzania bifenyloizoksazolosulfonamidów - Google Patents
Sposoby wytwarzania bifenyloizoksazolosulfonamidówInfo
- Publication number
- PL365567A1 PL365567A1 PL01365567A PL36556701A PL365567A1 PL 365567 A1 PL365567 A1 PL 365567A1 PL 01365567 A PL01365567 A PL 01365567A PL 36556701 A PL36556701 A PL 36556701A PL 365567 A1 PL365567 A1 PL 365567A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- methods
- isoxazole sulfonamides
- biphenyl isoxazole
- biphenyl
- Prior art date
Links
- KFJGHVOVYDCDOS-UHFFFAOYSA-N 1,1'-biphenyl;1,2-oxazole-3-sulfonamide Chemical class NS(=O)(=O)C=1C=CON=1.C1=CC=CC=C1C1=CC=CC=C1 KFJGHVOVYDCDOS-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C07D261/16—Benzene-sulfonamido isoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24090200P | 2000-10-17 | 2000-10-17 | |
| PCT/US2001/042741 WO2002032884A2 (en) | 2000-10-17 | 2001-10-12 | Methods for the preparation of biphenyl isoxazole sulfonamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL365567A1 true PL365567A1 (pl) | 2005-01-10 |
Family
ID=22908392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01365567A PL365567A1 (pl) | 2000-10-17 | 2001-10-12 | Sposoby wytwarzania bifenyloizoksazolosulfonamidów |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6639082B2 (pl) |
| EP (1) | EP1328523A2 (pl) |
| JP (1) | JP2004513098A (pl) |
| KR (1) | KR20030041168A (pl) |
| CN (1) | CN1501925A (pl) |
| AU (1) | AU2002232382A1 (pl) |
| BR (1) | BR0114709A (pl) |
| CA (1) | CA2425911A1 (pl) |
| CZ (1) | CZ20031369A3 (pl) |
| HU (1) | HUP0600606A2 (pl) |
| IL (1) | IL155318A0 (pl) |
| MX (1) | MXPA03003329A (pl) |
| PL (1) | PL365567A1 (pl) |
| WO (1) | WO2002032884A2 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6872849B2 (en) | 2002-11-08 | 2005-03-29 | Novo Nordisk A/S | Halo sulfonyl aryl boronates |
| JP2006505594A (ja) * | 2002-11-08 | 2006-02-16 | ノボ・ノルデイスク・エー／エス | ハロスルホニルアリールボロネート |
| EP1841504B1 (en) | 2005-01-13 | 2014-11-19 | Bristol-Myers Squibb Company | Substituted biaryl compounds as factor xia inhibitors |
| EP4050997A4 (en) | 2019-10-30 | 2022-11-30 | Perfuse Therapeutics, Inc. | TREATMENT OF EYE DISEASES USING ENDOTHELIN RECEPTOR ANTAGONISTS |
| CA3168810A1 (en) | 2020-02-06 | 2021-08-12 | Perfuse Therapeutics, Inc. | Compositions for treatment of ocular diseases |
| EP4329753A4 (en) | 2021-04-30 | 2025-02-26 | Perfuse Therapeutics, Inc. | PHARMACEUTICAL COMPOSITIONS AND INTRAVITREAL DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF EYE DISEASES |
| CN117105779A (zh) * | 2023-07-18 | 2023-11-24 | 河南师范大学 | 一种5-溴-2-甲酰基苯甲酸甲酯的制备方法 |
| IT202400000246A1 (it) * | 2024-01-09 | 2025-07-09 | Procos Spa | Processo per la preparazione di sparsentan |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2888455A (en) | 1956-09-04 | 1959-05-26 | Shionogi & Co | New sulfonamide and process for producing the same |
| DE1059459B (de) | 1956-09-04 | 1959-06-18 | Shionogi & Co | Verfahren zur Herstellung des therapeutisch wertvollen 3-Sulfanilamido-5-methylisoxazols |
| GB897440A (en) | 1960-02-08 | 1962-05-30 | Shionogi & Co | Improvements in or relating to sulfonamides |
| EP0194548A3 (de) | 1985-03-12 | 1988-08-17 | Dr. Karl Thomae GmbH | Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US5591761A (en) | 1993-05-20 | 1997-01-07 | Texas Biotechnology Corporation | Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5514691A (en) | 1993-05-20 | 1996-05-07 | Immunopharmaceutics, Inc. | N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5594021A (en) | 1993-05-20 | 1997-01-14 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5464853A (en) | 1993-05-20 | 1995-11-07 | Immunopharmaceutics, Inc. | N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5571821A (en) | 1993-05-20 | 1996-11-05 | Texas Biotechnology Corporation | Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| CA2005741C (en) | 1988-12-26 | 1998-06-02 | Hiroyoshi Hidaka | Quinoline sulfonoamino compounds having vessel smooth muscle relaxation activity |
| DE122007000050I1 (de) | 1990-02-19 | 2007-11-08 | Novartis Ag | Acylverbindungen |
| US5236928A (en) | 1991-03-19 | 1993-08-17 | Merck & Co., Inc. | Imidazole derivatives bearing acidic functional groups at the 5-position, their compositions and methods of use as angiotensin II antagonists |
| TW270116B (pl) | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
| RU2086544C1 (ru) | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| SE9103397D0 (sv) | 1991-11-18 | 1991-11-18 | Kabi Pharmacia Ab | Nya substituerade salicylsyror |
| US5378715A (en) | 1992-02-24 | 1995-01-03 | Bristol-Myers Squibb Co. | Sulfonamide endothelin antagonists |
| TW224462B (pl) | 1992-02-24 | 1994-06-01 | Squibb & Sons Inc | |
| US5514696A (en) | 1992-05-06 | 1996-05-07 | Bristol-Myers Squibb Co. | Phenyl sulfonamide endothelin antagonists |
| NZ247440A (en) | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
| TW287160B (pl) | 1992-12-10 | 1996-10-01 | Hoffmann La Roche | |
| TW394761B (en) | 1993-06-28 | 2000-06-21 | Hoffmann La Roche | Novel Sulfonylamino Pyrimidines |
| US5965732A (en) | 1993-08-30 | 1999-10-12 | Bristol-Myers Squibb Co. | Sulfonamide endothelin antagonists |
| US5612359A (en) | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
| CA2168154A1 (en) | 1995-02-06 | 1996-08-07 | Natesan Murugesan | Substituted biphenyl sulfonamide endothelin antagonists |
| US5760038A (en) | 1995-02-06 | 1998-06-02 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
| US5780473A (en) | 1995-02-06 | 1998-07-14 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
| ATE243203T1 (de) | 1995-04-04 | 2003-07-15 | Texas Biotechnology Corp | Thienyl-, furyl-, pyrrolyl- und biphenylsulfonamide und derivate zur modulation der endothelin-aktivität |
| UA58494C2 (uk) | 1995-06-07 | 2003-08-15 | Зенека Лімітед | Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну |
| GB9512697D0 (en) | 1995-06-22 | 1995-08-23 | Zeneca Ltd | Heterocyclic compounds |
| US5846990A (en) | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
| JP2001523218A (ja) | 1996-02-20 | 2001-11-20 | ブリストル―マイヤーズ・スクイブ・カンパニー | ビフェニルイソキサゾール・スルホンアミドの製造法 |
| US5856507A (en) | 1997-01-21 | 1999-01-05 | Bristol-Myers Squibb Co. | Methods for the preparation of biphenyl isoxazole sulfonamides |
| US5939446A (en) | 1996-04-09 | 1999-08-17 | Bristol-Myers Squibb Co. | Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists |
| TW536540B (en) | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
| AU3718900A (en) | 1999-03-19 | 2000-10-09 | Bristol-Myers Squibb Company | Methods for the preparation of biphenyl isoxazole sulfonamides |
| ATE339417T1 (de) | 1999-12-15 | 2006-10-15 | Bristol Myers Squibb Co | Biphenyl - sulfonamide als duale angiotensin - endothelin - rezeptor - antagonisten |
-
2001
- 2001-09-28 US US09/967,387 patent/US6639082B2/en not_active Expired - Fee Related
- 2001-10-12 WO PCT/US2001/042741 patent/WO2002032884A2/en not_active Ceased
- 2001-10-12 EP EP01987748A patent/EP1328523A2/en not_active Withdrawn
- 2001-10-12 CA CA002425911A patent/CA2425911A1/en not_active Abandoned
- 2001-10-12 JP JP2002536267A patent/JP2004513098A/ja active Pending
- 2001-10-12 KR KR10-2003-7005306A patent/KR20030041168A/ko not_active Withdrawn
- 2001-10-12 CN CNA01820659XA patent/CN1501925A/zh active Pending
- 2001-10-12 HU HU0600606A patent/HUP0600606A2/hu unknown
- 2001-10-12 IL IL15531801A patent/IL155318A0/xx unknown
- 2001-10-12 BR BR0114709-9A patent/BR0114709A/pt not_active IP Right Cessation
- 2001-10-12 MX MXPA03003329A patent/MXPA03003329A/es active IP Right Grant
- 2001-10-12 AU AU2002232382A patent/AU2002232382A1/en not_active Abandoned
- 2001-10-12 PL PL01365567A patent/PL365567A1/pl not_active Application Discontinuation
- 2001-10-12 CZ CZ20031369A patent/CZ20031369A3/cs unknown
-
2003
- 2003-08-12 US US10/639,228 patent/US20040059123A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1501925A (zh) | 2004-06-02 |
| US20020132838A1 (en) | 2002-09-19 |
| MXPA03003329A (es) | 2003-10-15 |
| JP2004513098A (ja) | 2004-04-30 |
| HUP0600606A2 (en) | 2006-11-28 |
| AU2002232382A1 (en) | 2002-04-29 |
| CA2425911A1 (en) | 2002-04-25 |
| US6639082B2 (en) | 2003-10-28 |
| WO2002032884A3 (en) | 2002-10-17 |
| EP1328523A2 (en) | 2003-07-23 |
| BR0114709A (pt) | 2004-06-15 |
| IL155318A0 (en) | 2003-11-23 |
| WO2002032884A2 (en) | 2002-04-25 |
| CZ20031369A3 (cs) | 2003-08-13 |
| KR20030041168A (ko) | 2003-05-23 |
| US20040059123A1 (en) | 2004-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU0103291D0 (en) | Process for the preparation of citalopram | |
| EE200300294A (et) | Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod | |
| IL187126A0 (en) | Process for the preparation of 4 - haloalkylnicotinonitriles | |
| IL154220A0 (en) | Process for the preparation of substituted phenylacetonitriles | |
| IL143106A (en) | Process for the preparation of diphenylmethylthioacetamide | |
| IL155318A0 (en) | Methods for the preparation of biphenyl isoxazole sulfonamides | |
| AU8824201A (en) | Process for the preparation of dinapsoline | |
| EP1300382A4 (en) | PROCESS FOR PREPARING LOWER OLEFINS | |
| IL124542A0 (en) | Methods for the preparation of biphenyl isoxazole sulfonamides | |
| IL150897A0 (en) | Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides | |
| NO20025465D0 (no) | FremgangsmÕte for fremstilling av bifenylforbindelser | |
| IL144708A0 (en) | Methods for the preparation of biphenyl isoxazole sulfonamide derivatives | |
| HUP0303025A3 (en) | Process for the preparation of arylethanoldiamines | |
| HK1055970A (en) | Methods for the preparation of biphenyl isoxazole sulfonamides | |
| MXPA03009210A (es) | PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS. | |
| IL190807A0 (en) | Process for the preparation of 2-aminoethylpyridines | |
| GB0016907D0 (en) | Cement mixers | |
| IL137364A (en) | Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol | |
| ITMI20000334A0 (it) | Procedimento di preparazione di miscele cementizie | |
| ZA200001843B (en) | Preparation of standard gas mixtures. | |
| PL368905A1 (pl) | Sposób otrzymywania beta-jonylidenoacetaldehydu | |
| IL154804A0 (en) | Process for the preparation of thiophenols | |
| GB0012249D0 (en) | Process for the preparation of 11-oxaprostaglandins | |
| ZA971289B (en) | Methods for the preparation of biphenyl isoxazole sulfonamides | |
| IL155995A0 (en) | New process for the preparation of diaryl-4-amino-piperidinyl compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |